Shuttle Pharmaceuticals Holdings, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
SHPH on Nasdaq
Location
401 Professional Drive, Suite 260, Gaithersburg, MD

There are no Buy or Sell transactions made by insiders since 4/23/2024

Shuttle Pharmaceuticals Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mira Jung Chief Scientific Officer $1.53M May 1, 2024
Anatoly Dritschilo CEO and Chairman, Director, 10%+ Owner $1.48M Aug 14, 2023
Milton Brown Director $161K Dec 31, 2024
Timothy J. Lorber Chief Financial Officer $105K Jun 13, 2024
Steven Richards Director $97.3K Dec 31, 2024
Joshua Schafer Director $97.3K Dec 31, 2024
George Scorsis Director $85.3K Feb 28, 2025
Oleh Nabyt Director $85.3K Feb 28, 2025
Joseph Tung Director $85.3K Feb 28, 2025
William Adkins Former Director $85.3K Dec 29, 2022
Bette Jacobs Director $62.6K Dec 13, 2023
Michael Vander Chief Financial Officer $48.1K Mar 8, 2024
Peter Dritschilo President and COO $3.04K Dec 29, 2022
Chris Senanayake Director $1.29K Dec 29, 2022
Tyvin Rich Chief Medical Officer $1.13K Dec 29, 2022
Chris Cooper Interim Co-CEO Mar 11, 2025

Recent Insider Transactions by Companies or Individuals for Shuttle Pharmaceuticals Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.